Seeking Alpha

Vivus (VVUS +0.2%) shares reverse course after suffering heavy losses earlier and hover around...

Vivus (VVUS +0.2%) shares reverse course after suffering heavy losses earlier and hover around zero after USA Today reports that the FDA has approved its Qnexa/Qysemia diet drug. However, no other news organizations appear to have reported the story, and it's not on the FDA website. Update: the linked-story in this MC seems to have been taken down. Vivus shares -0.6%.
Comments (18)
  • What's going on? It just dropped about 11%.
    17 Jul 2012, 01:38 PM Reply Like
  • And now the article is removed...
    17 Jul 2012, 01:41 PM Reply Like
  • Link removed @ USAToday. Update your story SA.
    17 Jul 2012, 01:41 PM Reply Like
  • Should we hope Harry Truman lost the election as published in the Chicago Tribune.
    17 Jul 2012, 01:43 PM Reply Like
  • USAToday and FOX get there news from same source...
    17 Jul 2012, 01:45 PM Reply Like
  • LOL Love the humor
    17 Jul 2012, 02:23 PM Reply Like
  • The suspense is killing me!! Hopefully trading will halt soon after an official announcement.
    17 Jul 2012, 01:57 PM Reply Like
  • Hang in there - should be soon.
    17 Jul 2012, 02:10 PM Reply Like
  • Very unusual for the FDA not to follow the panel recommendation, especially when it is 20 to 2 for approval.
    17 Jul 2012, 03:06 PM Reply Like
  • wow. this is some crazy stuff. pulled news articles now....what to make of all this......?
    17 Jul 2012, 03:09 PM Reply Like
  • I smell an after hours approval/rejection on this...
    17 Jul 2012, 03:10 PM Reply Like
  • that what i have been thinking is going to bee when the price was 28.45 and that why i sold the share in this price now is time to buy this share
    17 Jul 2012, 04:43 PM Reply Like
  • Does this late hour indicate a rejection, also, where on the fda web-site can we track the results.
    17 Jul 2012, 05:46 PM Reply Like
  • It's taking awhile for the FDA to release a decision, any speculation due to this delay?
    17 Jul 2012, 05:49 PM Reply Like
  • Wall St. Journal says Qsymia approved.
    17 Jul 2012, 07:58 PM Reply Like
  • Ihttp://nasdaq.cchwall...
    M-5250-1. Disclosure of Material Information


    Rule 5250(b)(1) requires that, except in unusual circumstances, Nasdaq Companies disclose promptly to the public through any Regulation FD compliant method (or combination of methods) of disclosure any material information that would reasonably be expected to affect the value of their securities or influence investors' decisions. Nasdaq Companies must notify Nasdaq at least ten minutes prior to the release to the public of material information that involves any of the events set forth below when the public release of the information is made during Nasdaq market hours (7:00 a.m. to 8:00 pm. ET). If the public release of the material information is made outside of Nasdaq market hours, Nasdaq Companies must notify MarketWatch of the material information prior to 6:50 a.m. ET. Under unusual circumstances Companies may not be required to make public disclosure of material events; for example, where it is possible to maintain confidentiality of those events and immediate public disclosure would prejudice the ability of the Company to pursue its legitimate corporate objectives. However, Nasdaq Companies remain obligated to disclose this information to Nasdaq upon request pursuant to Rule 5250(a).


    Whenever unusual market activity takes place in a Nasdaq Company's securities, the Company normally should determine whether there is material information or news which should be disclosed. If rumors or unusual market activity indicate that information on impending developments has become known to the investing public, or if information from a source other than the Company becomes known to the investing public, a clear public announcement may be required as to the state of negotiations or development of Company plans. Such an announcement may be required, even though the Company may not have previously been advised of such information or the matter has not yet been presented to the Company's Board of Directors for consideration. In certain circumstances, it may also be appropriate to publicly deny false or inaccurate rumors, which are likely to have, or have had, an effect on the trading in its securities or would likely have an influence on investment decisions.
    17 Jul 2012, 09:40 PM Reply Like
  • SA-can you tell us what ur thoughts are on this delay???
    17 Jul 2012, 09:47 PM Reply Like
  • approved
    17 Jul 2012, 09:52 PM Reply Like
DJIA (DIA) S&P 500 (SPY)